BioCardia Inc. share price logo

BioCardia Inc.

NASDAQ: BCDA

Small Cap

$0.90

-0.07

(-6.74%)

Live

as on

BioCardia Inc. Stock Performance

as on June 23, 2026 at 2:09 am IST

  • Day's Low

    Day's High

    $0.89
    $0.99
    downward going graph

    1.11%

    Downside

    10.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.78
    $2.45
    downward going graph

    13.72%

    Downside

    172.22%

    Upside

    downward going graph

BioCardia Inc. share price movements today

Previous Close
$0.97
Open
$0.95
Volume
1.4M
Day's Low - High
$0.89 - $0.99
52 Week Low - High
$0.78 - $2.45

BioCardia Inc. Historical Returns

1 Month Return
+ 1.3 %
3 Month Return
-19.38 %
1 Year Return
-53.49 %
3 Year Return
-97.3 %
5 Year Return
-98.67 %

BioCardia Inc. Stock Fundamentals & Key Indicators

Check BioCardia Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.4M

EPS (TTM)

-0.76

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-7.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-950.12%

BioCardia Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioCardia Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BioCardia Inc. image
BioCardia Inc.
BUY$14.4M-98.67%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.1B60.79%69.8712.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$114.6B139.12%26.835.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.9B14.22%14.8829.65%0.59%

Stock Returns calculator for BioCardia Inc. Stock including INR - Dollar returns

The BioCardia Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

BioCardia Inc. investment value today

Current value as on today

₹47,317

Returns

-₹52,683

(-52.68%)

Returns from BioCardia Inc. Stock

-₹56,731 (-56.73%)

Dollar Impact

₹4,048 (+4.05%)

Analyst Recommendation on BioCardia Inc. Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for BioCardia Inc.. Average target price of $15.5

BioCardia Inc. Share Price Target

Get share price movements and forecasts by analysts on BioCardia Inc..

What analysts predicted

94.19%UPSIDE

Target Price

$15.5

Current Price

$0.9

Analyzed by

8 Analysts

Target

$15.50

BioCardia Inc. target price $15.5, a slight upside of 94.19% compared to current price of $0.9. According to 8 analysts rating.

Indian Investors' Interest in BioCardia Inc. Stock

Search interest for BioCardia Inc. Stock has increased by 1770% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1770% versus previous 30 day period

BioCardia Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
0
0
-
-
-
-
-
Gross Profit
-1
-1
0
0
-1
-1
-1
0
0
0
Operating Income
-2
-2
-1
-1
-2
-2
-2
-1
-2
-2
EBITDA
-2
-2
-1
-1
-2
-2
-2
-1
-1
-2
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
-1
-1
-2
-2
-2
-1
-1
-2
Income Tax Expense
0
0
-
-
0
-
-
-
-
-
Net Income
-2
-2
-1
-1
-2
-2
-2
-1
-1
-2
Net Profit Margin
-15938.46%
-4121.82%
-54866.67%
-2994.83%
3958.62%
0.00%
0.00%
0.00%
0.00%
0.00%

BioCardia Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
0
1
1
0
0
-
Gross Profit
0
0
0
0
0
0
-10
-7
-4
0
Operating Income
-7
-12
-14
-14
-15
-12
-11
-11
-8
-8
EBITDA
-8
-12
-13
-14
-14
-12
-11
-11
-7
-7
Interest Expense
1
0
0
0
0
0
0
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-12
-13
-14
-15
-12
-11
-11
-7
-8
Income Tax Expense
5
0
0
0
0
0
0
0
-7
-
Net Income
-10
-12
-13
-14
-15
-12
-11
-11
-7
-8
Net Profit Margin
-1789.93%
-2569.52%
-2237.92%
-2071.69%
-10347.59%
-1243.45%
-881.14%
-2425.79%
-13700.00%
0.00%

BioCardia Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-2
-1
-1
-2
-2
-2
-1
-1
-2
Operating Cash Flow
-1
-1
-2
-2
-1
-1
-1
-2
-1
Investing Cash Flow
-
0
0
0
-
0
-
0
0
Financing Cash Flow
1
1
6
0
0
1
5
0
0
Change in Cash
0
0
3
-2
-1
0
4
-2
-1

BioCardia Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-13
-14
-15
-12
-11
-11
-7
-8
Operating Cash Flow
-8
-11
-9
-12
-10
-10
-9
-8
-7
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
3
9
28
1
5
3
9
7
Change in Cash
-8
-7
0
15
-8
-5
-6
1
0

Global Institutional Holdings in BioCardia Inc.

Funds
Holdings
Global Retirement Partners, LLC.
0%
Vanguard Group Inc
1.19%
CM Management, LLC
1.14%
DRW Securities, LLC
0%
Geode Capital Management, LLC
0.83%
See all

Insights on BioCardia Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BCDA stock has moved up by 16.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, BioCardia, Inc. Common Stock has experienced a drawdown of -97.3%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 75.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 73.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 58.0K → -58.0K (in $), with an average decrease of 200.0% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -1.48M → -2.25M (in $), with an average decrease of 23.8% per quarter

About BioCardia Inc.

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It also provides CardiALLO, an allogeneic mesenchymal stem cell therapy which is in phase II for ischemic heart failure; allogeneic cell therapy platform; and PulmALLO, an allogeneic mesenchymal stem cell therapy for acute respiratory distress syndrome. In addition, the company offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; Heart3D for fusion imaging; and morph DNA and avance steerable introducers. It has a license and distribution agreement with Biomet Biologics, LLC. BioCardia, Inc. is based in Sunnyvale, California.
OrganisationBioCardia Inc.
Headquarters320 Soquel Way, Sunnyvale, CA, United States, 94085
IndustryBiotechnology
CEODr. Peter A. Altman Ph.D.
E-voting on sharesClick here to vote

Key Management of BioCardia Inc.

Name

Title

Dr. Peter A. Altman Ph.D.

CEO, President & Director

Mr. David McClung

Chief Financial Officer

Mr. Edward M. Gillis

Senior Vice President of Devices

Ms. Miranda Peto Benvenuti

Investor Relations Executive

FAQs

What is BioCardia Inc. share price today?

BioCardia Inc. share price today is $0.9 as on . BioCardia Inc. share today touched a day high of $0.99 and a low of $0.89.

What is the 52 week high and 52 week low for BioCardia Inc. share?

BioCardia Inc. share touched a 52 week high of $2.45 on and a 52 week low of $0.78 on . BioCardia Inc. stock price today i.e. is trending at $0.9,which is 63.27% down from its 52 week high and 15.90% up from its 52 week low.

What is BioCardia Inc.'s market capitalisation today?

BioCardia Inc. market capitalisation is $0.00T as on .

How to invest in BioCardia Inc. Stock (BCDA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioCardia Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioCardia Inc. Shares that will get you 1.6667 shares as per BioCardia Inc. share price of $0.9 per share as on June 22, 2026 at 8:39 pm IST.

What is the minimum amount required to buy BioCardia Inc. Stock (BCDA) from India?

Indian investors can start investing in BioCardia Inc. (BCDA) shares with as little as ₹94.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.80 in BioCardia Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on BioCardia Inc. share’s latest price of $0.9 as on June 22, 2026 at 8:39 pm IST, you will get 11.1111 shares of BioCardia Inc.. Learn more about fractional shares .

What are the returns that BioCardia Inc. has given to Indian investors in the last 5 years?

BioCardia Inc. stock has given -98.67% share price returns and 26.88% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?